Sign up for our newsletter and get the latest HPC news and analysis.
Send me information from insideHPC:


Video: HPC at NIBR

“Focused on High Performance and Scientific Computing at Novartis Institutes for Biomedical Research (NIBR), in Basel Switzerland, Nick Holway and his team provide HPC resources and services, including programming and consultancy for the innovative research organization. Supporting more than 6,000 scientists, physicians and business professionals from around the world focused on developing medicines and devices that can produce positive real-world outcomes for patients and healthcare providers, Nick also contributes expertise in bioinformatics, image processing and data science in support of the researchers and their works.”

Supercomputing Drug Discovery to Combat Heart Disease

Using a unique computational approach to rapidly sample proteins in their natural state of gyrating, bobbing, and weaving, a research team from UC San Diego and Monash University in Australia has identified promising drug leads that may selectively combat heart disease, from arrhythmias to cardiac failure.

Insilico Applies Deep Learning to Drug Discovery

“The world of artificial intelligence is rapidly evolving and affecting every aspect of our daily life. And soon this progress will be felt in the pharmaceutical industry. We set up the Pharma.AI division to help pharmaceutical companies significantly accelerate their R&D and increase the number of approved drugs, but in the process we came up with over 800 strong hypotheses in oncology, cardiovascular, metabolic and CNS space and started basic validation. We are cautious about making strong statements, but if this approach works, it will uberize the pharmaceutical industry and generate unprecedented number of QALY,” said Alex Zhavoronkov, PhD, CEO of Insilico Medicine, Inc.

Accelerated Drug Discovery with Intel Xeon Phi

Drug discovery has accelerated with the advent of high performance computing and new algorithms. “A structural bioinformatics algorithm, eFindSuite, can be used to demonstrate how moving the code to a highly parallel implementation can speed up the computation, by using both the Intel Xeon processor and the Intel Xeon Phi coprocessor. eFindSuite is implemented in both Fortran 77 and C++.”

Video: HPC Tools to Discover New Drugs

“Intelligent Pharma is a biotechnology company dedicated to developing, commercializing and using new computational technologies for drug discovery. According to our clients’ needs, we carry out customized computational chemistry projects using cutting-edge technologies.”

Video: Drug Discovery Team Finds Inspiration at SDSC

“When Professor Ross Walker explains what he does for a living, he says he’s on the cutting edge of drug discovery research using supercomputers. Today, he and his team build supercomputer molecular biology software thanks in part to a partnership with Intel’s Software Academic Program. The program provides tools and resources to help Walker’s molecular dynamics lab develop highly effective supercomputer simulations.”

ISC’15 Will Move to a New City in Germany

The ISC’15 conference will be held July 12-16 in Frankfurt, Germany.

Could Apps be the Future of Informatics?

In this special feature from Scientific Computing World, Sean Ekins from Collaborative Drug Discovery explains to Robert Roe how science apps can be used for cheminformatics workflows. Delegates attending the SLAS2014 Conference in San Diego California from 18 to 22 January were able to download a conference app – available free from the iTunes store […]